Nanoparticle albumin-bound paclitaxel (nab-Paclitaxel): Bridging pharmacology and translational medicine in breast cancer.
- DOI
- 10.1016/j.retram.2025.103561
- Published
- 2026 Jan-Mar
- Container
- Current research in translational medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.retram.2025.103561,
title = {Nanoparticle albumin-bound paclitaxel (nab-Paclitaxel): Bridging pharmacology and translational medicine in breast cancer.},
author = {Alkhathami AG and Ahmed AT and Hussein A and R R and Tomar P and Al-Hetty HRAK and Panigrahi R and Chauhan AS and Hammady FJ and Salih SA},
year = {2026},
journal = {Current research in translational medicine},
doi = {10.1016/j.retram.2025.103561},
url = {https://doi.org/10.1016/j.retram.2025.103561}
}RIS
TY - JOUR TI - Nanoparticle albumin-bound paclitaxel (nab-Paclitaxel): Bridging pharmacology and translational medicine in breast cancer. AU - Alkhathami AG AU - Ahmed AT AU - Hussein A AU - R R AU - Tomar P AU - Al-Hetty HRAK AU - Panigrahi R AU - Chauhan AS AU - Hammady FJ AU - Salih SA PY - 2026 JO - Current research in translational medicine DO - 10.1016/j.retram.2025.103561 UR - https://doi.org/10.1016/j.retram.2025.103561 ER -
APA
AG, A., AT, A., A, H., R, R., P, T., HRAK, A., R, P., AS, C., FJ, H., & SA, S. (2026). Nanoparticle albumin-bound paclitaxel (nab-Paclitaxel): Bridging pharmacology and translational medicine in breast cancer.. Current research in translational medicine. https://doi.org/10.1016/j.retram.2025.103561
Source records
- pubmed · retrieved 2026-09-27T06:43:27.012Z